Oracle adds cloud features targeted at healthcare firms

During the company’s CloudWorld conference, the Fusion Enterprise Performance Management (EPM) suite as well as its Supply Chain and Manufacturing (SCM) and Human Capital Management (HCM) suite announced healthcare-centric features, CIO reports. With an eye on meeting the financial planning, supply chain, and human resource needs of customers in the healthcare industry, Oracle on Wednesday, October 19th, announced updates to its Cloud Fusion suite. A number of company suites have been updated, including Enterprise Performance Management (EPM), Supply Chain Management (SCM), and Human Capital Management (HCM).

As indicated by its $28 billion acquisition of healthcare systems maker Cerner in June 2022, Oracle is targeting the healthcare sector as a major target. The company said it was launching planning capabilities that could help healthcare companies optimize financial and operational management by modeling scenarios, determining future demand, optimizing resources, and helping users make better financial, workforce, and patient care decisions.

Related News

All News

Willum Þór: The question remains if our healthcare system is sustainable

On January 1st, Iceland took over the Presidency of the Nordic Council of Ministers. This intergovernmental organisation plays an important role in promoting innovations, health data integration, and cooperation between all major stakeholders in the Nordic healthcare. The Icelandic Health Minister elaborates on his vision to future health in the Nordic region, the Nordic strengths, Iceland’s plans for the Presidency with regards to health innovations, and the coming collaboration with Copenhagen Institute for Futures Studies

CIFS ran an all-day session at the Week of Health and Innovation (WHINN) in Odense

Copenhagen Institute for Futures Studies ran an all-day session at the annual Week of Health and Innovation (WHINN) in Odense, Denmark. CIFS’ program attracted over 40 experts from health and data organisations. We presented strategic foresight and futures studies in the health sector, concepts that are used to reimagine the future of the health sector, such as the Humanome and decentralised clinical trials. Also, we had a panel discussion on the newly started Phase V project on decentralised clinical trials, where CIFS is a contributing partner